Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Когнитивные нарушения при некоторых распространенных соматических заболеваниях: когнитивный резерв и терапевтические подходы
Когнитивные нарушения при некоторых распространенных соматических заболеваниях: когнитивный резерв и терапевтические подходы
Пизова Н.В. Когнитивные нарушения при некоторых распространенных соматических заболеваниях: когнитивный резерв и терапевтические подходы. Consilium Medicum. Неврология и ревматология (Прил.). 2015; 2: 27–32.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Когнитивные нарушения (КН) как один из симптомов поражения нервной системы нередко встречаются при разных соматических заболеваниях. Существуют убедительные данные о том, что при артериальной гипертензии, хронической сердечной недостаточности, нарушениях сердечного ритма, системных ревматических заболеваниях, гипотиреозе КН являются одним из основных проявлений поражения центральной нервной системы. Рассматриваются возможные механизмы повреждения нейронов головного мозга при некоторых соматических заболеваниях. Приводятся результаты рандомизированных клинических исследований, посвященных изучению эффективности применения витаминов у пациентов с КН. Отдельное внимание уделено витаминно-минеральному комплексу Беррока.
Ключевые слова: когнитивные нарушения, артериальная гипертензия, хроническая сердечная недостаточность, нарушения сердечного ритма, системная красная волчанка, гипотиреоз, профилактика, лечение, витамины группы В.
Key words: cognitive impairment, hypertension, chronic heart failure, heart rhythm disorders, systemic lupus erythematosus, hypothyroidism, prevention, treatment, vitamin B.
Ключевые слова: когнитивные нарушения, артериальная гипертензия, хроническая сердечная недостаточность, нарушения сердечного ритма, системная красная волчанка, гипотиреоз, профилактика, лечение, витамины группы В.
________________________________________________
Key words: cognitive impairment, hypertension, chronic heart failure, heart rhythm disorders, systemic lupus erythematosus, hypothyroidism, prevention, treatment, vitamin B.
Полный текст
Список литературы
1. Яхно Н.Н. Когнитивные расстройства в неврологической клинике. Неврол. журн. 2006; 11 (Прил. 1): 4–12. / Iakhno N.N. Kognitivnye rasstroistva v nevrologicheskoi klinike. Nevrol. zhurn. 2006; 11 (Pril. 1): 4–12. [in Russian]
2. Яхно Н.Н., Захаров В.В., Локшина А.Б. и др. Деменции. Руководство для врачей. 2-е изд. М.: МЕДпресс-информ, 2010. / Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlia vrachei. 2-e izd. M.: MEDpress-inform, 2010. [in Russian]
3. Larrabee GJ, Crook TM. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6 (1): 95–104.
4. Захаров В.В. Когнитивные нарушения в неврологической практике. Трудный пациент. 2005; 5: 15–8. / Zakharov V.V. Kognitivnye narusheniia v nevrologicheskoi praktike. Trudnyi patsient. 2005; 5: 15–8. [in Russian]
5. Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001.
6. Jonsson L, Gustavsson A, Cortes F et al. International differences in Resource Use and Cost of Care in alzgeimer’s disease: baseline data from the Ictus Study. Neurodegenerative Dis 2007; 4 (1): 122.
7. Лурия А.Р. Основы нейропсихологии. М.: Изд-во МГУ, 1973. / Luriia A.R. Osnovy neiropsikhologii. M.: Izd-vo MGU, 1973. [in Russian]
8. Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. Под ред. Н.Н.Яхно. М., 2002. / Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002. [in Russian]
9. Дамулин И.В. Сосудистые когнитивные нарушения: клинические и терапевтические аспекты. Рус. мед. журн. 2006; 9: 658–64. / Damulin I.V. Sosudistye kognitivnye narusheniia: klinicheskie i terapevticheskie aspekty. Rus. med. zhurn. 2006; 9: 658–64. [in Russian]
10. Geroldi C, Ferrucci L, Bandinelli S et al. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J Am Ger Soc 2003; 51: 1064–71.
11. Варакин Ю.Я. Профилактика нарушений мозгового кровообращения. Очерки ангионеврологии. Ред. З.А.Суслина. М., 2005. / Varakin Iu.Ia. Profilaktika narushenii mozgovogo krovoobrashcheniia. Ocherki angionevrologii. Red. Z.A.Suslina. M., 2005. [in Russian]
12. De Leeuw FE, van Gijn J. Vascular dementia. Pract Neurol 2003; 3: 86–91.
13. Elias PK, Elias MF, Robbins MA et al. Blood Pressure-Related Cognitive Decline. Does Age Make a Difference? Hypertension 2004; 44: 631–6.
14. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–85.
15. Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005; 58: 1308–15.
16. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure level and late–life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274 (23): 1846–51.
17. Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс-информ, 2010. / Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M.: MEDpress-inform, 2010. [in Russian]
18. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive functions in healthy old people. J Am Geriatr Soc 1993; 41: 153–6.
19. Киландер Л., Ниман Н., Боберг М. и др. Взаимосвязь артериальной гипертензии с когнитивными нарушениями: Результаты 20-летнего наблюдения 999 пациентов. Обзоры клин. кардиологии. 2005; 2: 37–49. / Kilander L., Niman N., Boberg M. i dr. Vzaimosviaz' arterial'noi gipertenzii s kognitivnymi narusheniiami: Rezul'taty 20-letnego nabliudeniia 999 patsientov. Obzory klin. kardiologii. 2005; 2: 37–49. [in Russian]
20. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
21. Vogels RLC, Scheltens P, Schroeder-Tanka JM., Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Failure 2007; 9 (5): 440–9.
22. Vogels RLC, Oosterman JM, Van Harten B et al. Profile of cognitive impairment in chronic heart failure. J Ame Geriatr Soc 2007; 55 (11): 1764–70.
23. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract 2011; 23 (11): 577–85.
24. Pullicino PM, Hart J. Cognitive Impairment in congestive heart failure. Neurology 2001; 57 (11): 1945–6.
25. Алехин А.Н., Трифонова Е.А., Лебедев Д.С., Михайлов Е.Н. Психологические проблемы в аритмологии (на модели фибрилляции предсердий). Вестн. аритмологии. 2011; 63 (63): 45–54. / Alekhin A.N., Trifonova E.A., Lebedev D.S., Mikhailov E.N. Psikhologicheskie problemy v aritmologii (na modeli fibrilliatsii predserdii). Vestn. aritmologii. 2011; 63 (63): 45–54. [in Russian]
26. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol 2009; 57 (2): 143–50.
27. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. K.Rockwood, S.Gauthier, editors. London & New York: Taylor a Francis; 2006; p. 189–212.
28. Левин О.С. Когнитивные нарушения в практике терапевта: заболевания сердечно-сосудистой системы. Consilium Medicum. 2009; 11 (2): 55–61. / Levin O.S. Kognitivnye narusheniia v praktike terapevta: zabolevaniia serdechno-sosudistoi sistemy. Consilium Medicum. 2009; 11 (2): 55–61. [in Russian]
29. Lane DA, Langman СМ, Lip GY. Illness perceptions, affective response, and healthrelated quality of life in patients with atrial fibrillation. J Psychosom Res 2009; 66 (3): 203–10.
30. Shi J, Yang SH, Stubley L et al. Hypoperfusion induces overexpression of betaamyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853 (1): 1–4.
31. Sparks DL, Scheff SW, Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131 (2): 162–9.
32. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002; 26 (1): 45–60.
33. Abend WK, Tyler H.R. Thyroid disease and the Nervous System. In: Neurology and General Medicine. The Neurological Aspects of Medical Disorders. Second edition. Ed. by M.J.Aminoff. Chapter 18. New York etc.: Churchill Livingstone 1995; p. 333–47.
34. Дамулин И.В., Оразмурадов Г.О. Неврологические нарушения при гипотиреозе. Журн. неврологии и психиатрии. 2011; 111 (3): 82–6. / Damulin I.V., Orazmuradov G.O. Nevrologicheskie narusheniia pri gipotireoze. Zhurn. nevrologii i psikhiatrii. 2011; 111 (3): 82–6. [in Russian]
35. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. Chapter 1:Disorders of Consciousness. New York etc.: Lange Medical Books McGraw-Hill, 2002; p. 1–70.
36. Carlomagni S, Migliaresi S, Ambrosone L et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000; 247: 273–9.
37. Glanz BI, Slonim D, Urowitz MB et al. Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 232–8.
38. Hanly JG, Fisk JD, Sherwood G et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7.
39. Hay EM, Black D, Huddy A et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6.
40. Kozora E, Thompson LL, West SG et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45.
41. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions. Neurology 2002; 58: 1214–20.
42. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006; 85 (4): 221–8.
43. Пизова Н.В. Когнитивные нарушения при системной красной волчанке. Журн. неврологии и психиатрии им. С.С.Корсакова. 2013; 12 (113): 113–7. / Pizova N.V. Kognitivnye narusheniia pri sistemnoi krasnoi volchanke. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2013; 12 (113): 113–7. [in Russian]
44. Laurin Mc, Holliday SL, Williams P et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64 (2): 297–303.
45. Gladman DD, Urowitz MB, Slonim D et al. Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol 2000; 27 (10): 2367–71.
46. Rogers MP, Waterhouse E, Nagel JS et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1 (4): 215–9.
47. Tomietto P, Annese V, D'Agostini S et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo 2003; 55 (3): 171–80.
48. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001; 248 (7): 595–602.
49. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728–34.
50. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsyhol Soc 2002; 8 (3): 448–60.
51. Perneczky R, Alexopoulos P, Schmid G еt al. Cognitive reserve and its relevance for the prevention and diagnosis of dementia. Nervenarzt 2011; 82 (3): 325–30, 332–5.
52. Scarmeas N, Zarahn E, Anderson K et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003; 60: 359–65.
53. Ghaffar N, Fiati M, Feinstein A. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS 2012; 7 (10): 47206.
54. Bialystok E, Craik F, Klein R, Viswanathan M. Bilingualism, aging, and cognitive control: evidence from the Simon task. Psychology and Aging 2004; 19: 290–303.
55. Bak TH, Nissan JJ, Allerhand MM, Deary IJ. Does bilingualism influence cognitive aging? Ann Neurol 2014; 75 (6): 959–63.
56. Sole-Padulles C, Bartres-Faz D, Junque C et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009; 30 (7): 1114–24.
57. Erickson KI, Voss MW, Prakash RS et al. Exercise training increases size of hippocampus and improves memory. PNAS (Proceedings of the National Academy of Sciences of the USA). 2011; 108 (7): 3017–22.
58. Слободин Т.Н., Горева А.В. Когнитивный резерв: причины снижения и защитный механизмы. Междунар. неврол. журн. 2012; 3 (49): 45–51. / Slobodin T.N., Goreva A.V. Kognitivnyi rezerv: prichiny snizheniia i zashchitnyi mekhanizmy. Mezhdunar. nevrol. zhurn. 2012; 3 (49): 45–51. [in Russian]
59. Fernandes MA, Craik F, Bialystok E, Kreuger S et al. Effects of bilingualism, aging, and semantic relatedness on memory under divided attention. Can J Experim Psychol Revue canadienne de psychologieexperimentale. 2007; 61 (2): 128–41.
60. Stern Y. Exploring the neural basis of cognitive reserve. J Clin Experim Neuropsychol 2003; 25 (5): 691–701.
61. Eckroth-Bucher M, Siberski J. Am J Alzheimers Dis Other Dement 2009; 24 (3): 234–45.
62. Willis S, Tennstedt S, Marsiske M et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296 (25): 2805–14.
63. Гаврилова С.И. Фармакотерапия болезни Альцгеймера. 2-е изд., перераб. и доп. М., 2007; c. 360. / Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; c. 360. [in Russian]
64. Захаров В.В., Яхно Н.Н. Нарушения памяти. М., 2003; с. 150. / Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M., 2003; s. 150. [in Russian]
65. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res and Pract Alzheimer’s Dis 2001; 5: 57–68.
66. Преображенская И.С. Ноотропные препараты в гериатрической практике. РМЖ. 2004; 5 (12): 256–61. / Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh. 2004; 5 (12): 256–61. [in Russian]
67. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
68. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer's Dis 2012; 29: 561–9.
69. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
70. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
71. Kennedy DO, Vease R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
72. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
73. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
74. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B-Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
75. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
76. www.berocca.ru
77. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
78. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.
79. Студеникин В.М., Курбайтаева Э.М. Кальциопенические состояния и их коррекция. Лечащий врач. 2010; 10: 54–6. / Studenikin V.M., Kurbaitaeva E.M. Kal'tsiopenicheskie sostoianiia i ikh korrektsiia. Lechashchii vrach. 2010; 10: 54–6. [in Russian]
80. Студеникин В.М., Турсунхужаева С.Ш., Шелковский В.И. Цинк в нейропедиатрии и нейродиетологии. Лечащий врач. 2012; 1: 44–7. / Studenikin V.M., Tursunkhuzhaeva S.Sh., Shelkovskii V.I. Tsink v neiropediatrii i neirodietologii. Lechashchii vrach. 2012; 1: 44–7. [in Russian]
81. Студеникин В.М., Турсунхужаева С.Ш., Звонкова Н.Г. и др. Магний и его препараты в психоневрологии. Эффективная фармакотерапия. Неврология и психиатрия. 2012; 4 (8–12): 58–60. / Studenikin V.M., Tursunkhuzhaeva S.Sh., Zvonkova N.G. i dr. Magnii i ego preparaty v psikhonevrologii. Effektivnaia farmakoterapiia. Nevrologiia i psikhiatriia. 2012; 4 (8–12): 58–60. [in Russian]
2. Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlia vrachei. 2-e izd. M.: MEDpress-inform, 2010. [in Russian]
3. Larrabee GJ, Crook TM. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6 (1): 95–104.
4. Zakharov V.V. Kognitivnye narusheniia v nevrologicheskoi praktike. Trudnyi patsient. 2005; 5: 15–8. [in Russian]
5. Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001.
6. Jonsson L, Gustavsson A, Cortes F et al. International differences in Resource Use and Cost of Care in alzgeimer’s disease: baseline data from the Ictus Study. Neurodegenerative Dis 2007; 4 (1): 122.
7. Luriia A.R. Osnovy neiropsikhologii. M.: Izd-vo MGU, 1973. [in Russian]
8. Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002. [in Russian]
9. Damulin I.V. Sosudistye kognitivnye narusheniia: klinicheskie i terapevticheskie aspekty. Rus. med. zhurn. 2006; 9: 658–64. [in Russian]
10. Geroldi C, Ferrucci L, Bandinelli S et al. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J Am Ger Soc 2003; 51: 1064–71.
11. Varakin Iu.Ia. Profilaktika narushenii mozgovogo krovoobrashcheniia. Ocherki angionevrologii. Red. Z.A.Suslina. M., 2005. [in Russian]
12. De Leeuw FE, van Gijn J. Vascular dementia. Pract Neurol 2003; 3: 86–91.
13. Elias PK, Elias MF, Robbins MA et al. Blood Pressure-Related Cognitive Decline. Does Age Make a Difference? Hypertension 2004; 44: 631–6.
14. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–85.
15. Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005; 58: 1308–15.
16. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure level and late–life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274 (23): 1846–51.
17. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M.: MEDpress-inform, 2010. [in Russian]
18. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive functions in healthy old people. J Am Geriatr Soc 1993; 41: 153–6.
19. Kilander L., Niman N., Boberg M. i dr. Vzaimosviaz' arterial'noi gipertenzii s kognitivnymi narusheniiami: Rezul'taty 20-letnego nabliudeniia 999 patsientov. Obzory klin. kardiologii. 2005; 2: 37–49. [in Russian]
20. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
21. Vogels RLC, Scheltens P, Schroeder-Tanka JM., Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Failure 2007; 9 (5): 440–9.
22. Vogels RLC, Oosterman JM, Van Harten B et al. Profile of cognitive impairment in chronic heart failure. J Ame Geriatr Soc 2007; 55 (11): 1764–70.
23. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract 2011; 23 (11): 577–85.
24. Pullicino PM, Hart J. Cognitive Impairment in congestive heart failure. Neurology 2001; 57 (11): 1945–6.
25. Alekhin A.N., Trifonova E.A., Lebedev D.S., Mikhailov E.N. Psikhologicheskie problemy v aritmologii (na modeli fibrilliatsii predserdii). Vestn. aritmologii. 2011; 63 (63): 45–54. [in Russian]
26. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol 2009; 57 (2): 143–50.
27. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. K.Rockwood, S.Gauthier, editors. London & New York: Taylor a Francis; 2006; p. 189–212.
28. Levin O.S. Kognitivnye narusheniia v praktike terapevta: zabolevaniia serdechno-sosudistoi sistemy. Consilium Medicum. 2009; 11 (2): 55–61. [in Russian]
29. Lane DA, Langman СМ, Lip GY. Illness perceptions, affective response, and healthrelated quality of life in patients with atrial fibrillation. J Psychosom Res 2009; 66 (3): 203–10.
30. Shi J, Yang SH, Stubley L et al. Hypoperfusion induces overexpression of betaamyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853 (1): 1–4.
31. Sparks DL, Scheff SW, Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131 (2): 162–9.
32. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002; 26 (1): 45–60.
33. Abend WK, Tyler H.R. Thyroid disease and the Nervous System. In: Neurology and General Medicine. The Neurological Aspects of Medical Disorders. Second edition. Ed. by M.J.Aminoff. Chapter 18. New York etc.: Churchill Livingstone 1995; p. 333–47.
34. Damulin I.V., Orazmuradov G.O. Nevrologicheskie narusheniia pri gipotireoze. Zhurn. nevrologii i psikhiatrii. 2011; 111 (3): 82–6. [in Russian]
35. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. Chapter 1:Disorders of Consciousness. New York etc.: Lange Medical Books McGraw-Hill, 2002; p. 1–70.
36. Carlomagni S, Migliaresi S, Ambrosone L et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000; 247: 273–9.
37. Glanz BI, Slonim D, Urowitz MB et al. Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 232–8.
38. Hanly JG, Fisk JD, Sherwood G et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7.
39. Hay EM, Black D, Huddy A et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6.
40. Kozora E, Thompson LL, West SG et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45.
41. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions. Neurology 2002; 58: 1214–20.
42. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006; 85 (4): 221–8.
43. Pizova N.V. Kognitivnye narusheniia pri sistemnoi krasnoi volchanke. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2013; 12 (113): 113–7. [in Russian]
44. Laurin Mc, Holliday SL, Williams P et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64 (2): 297–303.
45. Gladman DD, Urowitz MB, Slonim D et al. Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol 2000; 27 (10): 2367–71.
46. Rogers MP, Waterhouse E, Nagel JS et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1 (4): 215–9.
47. Tomietto P, Annese V, D'Agostini S et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo 2003; 55 (3): 171–80.
48. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001; 248 (7): 595–602.
49. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728–34.
50. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsyhol Soc 2002; 8 (3): 448–60.
51. Perneczky R, Alexopoulos P, Schmid G еt al. Cognitive reserve and its relevance for the prevention and diagnosis of dementia. Nervenarzt 2011; 82 (3): 325–30, 332–5.
52. Scarmeas N, Zarahn E, Anderson K et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003; 60: 359–65.
53. Ghaffar N, Fiati M, Feinstein A. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS 2012; 7 (10): 47206.
54. Bialystok E, Craik F, Klein R, Viswanathan M. Bilingualism, aging, and cognitive control: evidence from the Simon task. Psychology and Aging 2004; 19: 290–303.
55. Bak TH, Nissan JJ, Allerhand MM, Deary IJ. Does bilingualism influence cognitive aging? Ann Neurol 2014; 75 (6): 959–63.
56. Sole-Padulles C, Bartres-Faz D, Junque C et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009; 30 (7): 1114–24.
57. Erickson KI, Voss MW, Prakash RS et al. Exercise training increases size of hippocampus and improves memory. PNAS (Proceedings of the National Academy of Sciences of the USA). 2011; 108 (7): 3017–22.
58. Slobodin T.N., Goreva A.V. Kognitivnyi rezerv: prichiny snizheniia i zashchitnyi mekhanizmy. Mezhdunar. nevrol. zhurn. 2012; 3 (49): 45–51. [in Russian]
59. Fernandes MA, Craik F, Bialystok E, Kreuger S et al. Effects of bilingualism, aging, and semantic relatedness on memory under divided attention. Can J Experim Psychol Revue canadienne de psychologieexperimentale. 2007; 61 (2): 128–41.
60. Stern Y. Exploring the neural basis of cognitive reserve. J Clin Experim Neuropsychol 2003; 25 (5): 691–701.
61. Eckroth-Bucher M, Siberski J. Am J Alzheimers Dis Other Dement 2009; 24 (3): 234–45.
62. Willis S, Tennstedt S, Marsiske M et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296 (25): 2805–14.
63. Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; c. 360. [in Russian]
64. Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M., 2003; s. 150. [in Russian]
65. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res and Pract Alzheimer’s Dis 2001; 5: 57–68.
66. Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh. 2004; 5 (12): 256–61. [in Russian]
67. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
68. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer's Dis 2012; 29: 561–9.
69. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
70. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
71. Kennedy DO, Vease R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
72. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
73. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
74. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B-Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
75. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
76. www.berocca.ru
77. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
78. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.
79. Studenikin V.M., Kurbaitaeva E.M. Kal'tsiopenicheskie sostoianiia i ikh korrektsiia. Lechashchii vrach. 2010; 10: 54–6. [in Russian]
80. Studenikin V.M., Tursunkhuzhaeva S.Sh., Shelkovskii V.I. Tsink v neiropediatrii i neirodietologii. Lechashchii vrach. 2012; 1: 44–7. [in Russian]
81. Studenikin V.M., Tursunkhuzhaeva S.Sh., Zvonkova N.G. i dr. Magnii i ego preparaty v psikhonevrologii. Effektivnaia farmakoterapiia. Nevrologiia i psikhiatriia. 2012; 4 (8–12): 58–60. [in Russian]
2. Яхно Н.Н., Захаров В.В., Локшина А.Б. и др. Деменции. Руководство для врачей. 2-е изд. М.: МЕДпресс-информ, 2010. / Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlia vrachei. 2-e izd. M.: MEDpress-inform, 2010. [in Russian]
3. Larrabee GJ, Crook TM. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6 (1): 95–104.
4. Захаров В.В. Когнитивные нарушения в неврологической практике. Трудный пациент. 2005; 5: 15–8. / Zakharov V.V. Kognitivnye narusheniia v nevrologicheskoi praktike. Trudnyi patsient. 2005; 5: 15–8. [in Russian]
5. Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001.
6. Jonsson L, Gustavsson A, Cortes F et al. International differences in Resource Use and Cost of Care in alzgeimer’s disease: baseline data from the Ictus Study. Neurodegenerative Dis 2007; 4 (1): 122.
7. Лурия А.Р. Основы нейропсихологии. М.: Изд-во МГУ, 1973. / Luriia A.R. Osnovy neiropsikhologii. M.: Izd-vo MGU, 1973. [in Russian]
8. Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. Под ред. Н.Н.Яхно. М., 2002. / Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002. [in Russian]
9. Дамулин И.В. Сосудистые когнитивные нарушения: клинические и терапевтические аспекты. Рус. мед. журн. 2006; 9: 658–64. / Damulin I.V. Sosudistye kognitivnye narusheniia: klinicheskie i terapevticheskie aspekty. Rus. med. zhurn. 2006; 9: 658–64. [in Russian]
10. Geroldi C, Ferrucci L, Bandinelli S et al. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J Am Ger Soc 2003; 51: 1064–71.
11. Варакин Ю.Я. Профилактика нарушений мозгового кровообращения. Очерки ангионеврологии. Ред. З.А.Суслина. М., 2005. / Varakin Iu.Ia. Profilaktika narushenii mozgovogo krovoobrashcheniia. Ocherki angionevrologii. Red. Z.A.Suslina. M., 2005. [in Russian]
12. De Leeuw FE, van Gijn J. Vascular dementia. Pract Neurol 2003; 3: 86–91.
13. Elias PK, Elias MF, Robbins MA et al. Blood Pressure-Related Cognitive Decline. Does Age Make a Difference? Hypertension 2004; 44: 631–6.
14. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–85.
15. Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005; 58: 1308–15.
16. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure level and late–life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274 (23): 1846–51.
17. Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс-информ, 2010. / Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M.: MEDpress-inform, 2010. [in Russian]
18. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive functions in healthy old people. J Am Geriatr Soc 1993; 41: 153–6.
19. Киландер Л., Ниман Н., Боберг М. и др. Взаимосвязь артериальной гипертензии с когнитивными нарушениями: Результаты 20-летнего наблюдения 999 пациентов. Обзоры клин. кардиологии. 2005; 2: 37–49. / Kilander L., Niman N., Boberg M. i dr. Vzaimosviaz' arterial'noi gipertenzii s kognitivnymi narusheniiami: Rezul'taty 20-letnego nabliudeniia 999 patsientov. Obzory klin. kardiologii. 2005; 2: 37–49. [in Russian]
20. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
21. Vogels RLC, Scheltens P, Schroeder-Tanka JM., Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Failure 2007; 9 (5): 440–9.
22. Vogels RLC, Oosterman JM, Van Harten B et al. Profile of cognitive impairment in chronic heart failure. J Ame Geriatr Soc 2007; 55 (11): 1764–70.
23. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract 2011; 23 (11): 577–85.
24. Pullicino PM, Hart J. Cognitive Impairment in congestive heart failure. Neurology 2001; 57 (11): 1945–6.
25. Алехин А.Н., Трифонова Е.А., Лебедев Д.С., Михайлов Е.Н. Психологические проблемы в аритмологии (на модели фибрилляции предсердий). Вестн. аритмологии. 2011; 63 (63): 45–54. / Alekhin A.N., Trifonova E.A., Lebedev D.S., Mikhailov E.N. Psikhologicheskie problemy v aritmologii (na modeli fibrilliatsii predserdii). Vestn. aritmologii. 2011; 63 (63): 45–54. [in Russian]
26. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol 2009; 57 (2): 143–50.
27. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. K.Rockwood, S.Gauthier, editors. London & New York: Taylor a Francis; 2006; p. 189–212.
28. Левин О.С. Когнитивные нарушения в практике терапевта: заболевания сердечно-сосудистой системы. Consilium Medicum. 2009; 11 (2): 55–61. / Levin O.S. Kognitivnye narusheniia v praktike terapevta: zabolevaniia serdechno-sosudistoi sistemy. Consilium Medicum. 2009; 11 (2): 55–61. [in Russian]
29. Lane DA, Langman СМ, Lip GY. Illness perceptions, affective response, and healthrelated quality of life in patients with atrial fibrillation. J Psychosom Res 2009; 66 (3): 203–10.
30. Shi J, Yang SH, Stubley L et al. Hypoperfusion induces overexpression of betaamyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853 (1): 1–4.
31. Sparks DL, Scheff SW, Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131 (2): 162–9.
32. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002; 26 (1): 45–60.
33. Abend WK, Tyler H.R. Thyroid disease and the Nervous System. In: Neurology and General Medicine. The Neurological Aspects of Medical Disorders. Second edition. Ed. by M.J.Aminoff. Chapter 18. New York etc.: Churchill Livingstone 1995; p. 333–47.
34. Дамулин И.В., Оразмурадов Г.О. Неврологические нарушения при гипотиреозе. Журн. неврологии и психиатрии. 2011; 111 (3): 82–6. / Damulin I.V., Orazmuradov G.O. Nevrologicheskie narusheniia pri gipotireoze. Zhurn. nevrologii i psikhiatrii. 2011; 111 (3): 82–6. [in Russian]
35. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. Chapter 1:Disorders of Consciousness. New York etc.: Lange Medical Books McGraw-Hill, 2002; p. 1–70.
36. Carlomagni S, Migliaresi S, Ambrosone L et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000; 247: 273–9.
37. Glanz BI, Slonim D, Urowitz MB et al. Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 232–8.
38. Hanly JG, Fisk JD, Sherwood G et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7.
39. Hay EM, Black D, Huddy A et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6.
40. Kozora E, Thompson LL, West SG et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45.
41. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions. Neurology 2002; 58: 1214–20.
42. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006; 85 (4): 221–8.
43. Пизова Н.В. Когнитивные нарушения при системной красной волчанке. Журн. неврологии и психиатрии им. С.С.Корсакова. 2013; 12 (113): 113–7. / Pizova N.V. Kognitivnye narusheniia pri sistemnoi krasnoi volchanke. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2013; 12 (113): 113–7. [in Russian]
44. Laurin Mc, Holliday SL, Williams P et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64 (2): 297–303.
45. Gladman DD, Urowitz MB, Slonim D et al. Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol 2000; 27 (10): 2367–71.
46. Rogers MP, Waterhouse E, Nagel JS et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1 (4): 215–9.
47. Tomietto P, Annese V, D'Agostini S et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo 2003; 55 (3): 171–80.
48. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001; 248 (7): 595–602.
49. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728–34.
50. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsyhol Soc 2002; 8 (3): 448–60.
51. Perneczky R, Alexopoulos P, Schmid G еt al. Cognitive reserve and its relevance for the prevention and diagnosis of dementia. Nervenarzt 2011; 82 (3): 325–30, 332–5.
52. Scarmeas N, Zarahn E, Anderson K et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003; 60: 359–65.
53. Ghaffar N, Fiati M, Feinstein A. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS 2012; 7 (10): 47206.
54. Bialystok E, Craik F, Klein R, Viswanathan M. Bilingualism, aging, and cognitive control: evidence from the Simon task. Psychology and Aging 2004; 19: 290–303.
55. Bak TH, Nissan JJ, Allerhand MM, Deary IJ. Does bilingualism influence cognitive aging? Ann Neurol 2014; 75 (6): 959–63.
56. Sole-Padulles C, Bartres-Faz D, Junque C et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009; 30 (7): 1114–24.
57. Erickson KI, Voss MW, Prakash RS et al. Exercise training increases size of hippocampus and improves memory. PNAS (Proceedings of the National Academy of Sciences of the USA). 2011; 108 (7): 3017–22.
58. Слободин Т.Н., Горева А.В. Когнитивный резерв: причины снижения и защитный механизмы. Междунар. неврол. журн. 2012; 3 (49): 45–51. / Slobodin T.N., Goreva A.V. Kognitivnyi rezerv: prichiny snizheniia i zashchitnyi mekhanizmy. Mezhdunar. nevrol. zhurn. 2012; 3 (49): 45–51. [in Russian]
59. Fernandes MA, Craik F, Bialystok E, Kreuger S et al. Effects of bilingualism, aging, and semantic relatedness on memory under divided attention. Can J Experim Psychol Revue canadienne de psychologieexperimentale. 2007; 61 (2): 128–41.
60. Stern Y. Exploring the neural basis of cognitive reserve. J Clin Experim Neuropsychol 2003; 25 (5): 691–701.
61. Eckroth-Bucher M, Siberski J. Am J Alzheimers Dis Other Dement 2009; 24 (3): 234–45.
62. Willis S, Tennstedt S, Marsiske M et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296 (25): 2805–14.
63. Гаврилова С.И. Фармакотерапия болезни Альцгеймера. 2-е изд., перераб. и доп. М., 2007; c. 360. / Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; c. 360. [in Russian]
64. Захаров В.В., Яхно Н.Н. Нарушения памяти. М., 2003; с. 150. / Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M., 2003; s. 150. [in Russian]
65. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res and Pract Alzheimer’s Dis 2001; 5: 57–68.
66. Преображенская И.С. Ноотропные препараты в гериатрической практике. РМЖ. 2004; 5 (12): 256–61. / Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh. 2004; 5 (12): 256–61. [in Russian]
67. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
68. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer's Dis 2012; 29: 561–9.
69. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
70. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
71. Kennedy DO, Vease R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
72. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
73. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
74. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B-Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
75. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
76. www.berocca.ru
77. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
78. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.
79. Студеникин В.М., Курбайтаева Э.М. Кальциопенические состояния и их коррекция. Лечащий врач. 2010; 10: 54–6. / Studenikin V.M., Kurbaitaeva E.M. Kal'tsiopenicheskie sostoianiia i ikh korrektsiia. Lechashchii vrach. 2010; 10: 54–6. [in Russian]
80. Студеникин В.М., Турсунхужаева С.Ш., Шелковский В.И. Цинк в нейропедиатрии и нейродиетологии. Лечащий врач. 2012; 1: 44–7. / Studenikin V.M., Tursunkhuzhaeva S.Sh., Shelkovskii V.I. Tsink v neiropediatrii i neirodietologii. Lechashchii vrach. 2012; 1: 44–7. [in Russian]
81. Студеникин В.М., Турсунхужаева С.Ш., Звонкова Н.Г. и др. Магний и его препараты в психоневрологии. Эффективная фармакотерапия. Неврология и психиатрия. 2012; 4 (8–12): 58–60. / Studenikin V.M., Tursunkhuzhaeva S.Sh., Zvonkova N.G. i dr. Magnii i ego preparaty v psikhonevrologii. Effektivnaia farmakoterapiia. Nevrologiia i psikhiatriia. 2012; 4 (8–12): 58–60. [in Russian]
________________________________________________
2. Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlia vrachei. 2-e izd. M.: MEDpress-inform, 2010. [in Russian]
3. Larrabee GJ, Crook TM. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6 (1): 95–104.
4. Zakharov V.V. Kognitivnye narusheniia v nevrologicheskoi praktike. Trudnyi patsient. 2005; 5: 15–8. [in Russian]
5. Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001.
6. Jonsson L, Gustavsson A, Cortes F et al. International differences in Resource Use and Cost of Care in alzgeimer’s disease: baseline data from the Ictus Study. Neurodegenerative Dis 2007; 4 (1): 122.
7. Luriia A.R. Osnovy neiropsikhologii. M.: Izd-vo MGU, 1973. [in Russian]
8. Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002. [in Russian]
9. Damulin I.V. Sosudistye kognitivnye narusheniia: klinicheskie i terapevticheskie aspekty. Rus. med. zhurn. 2006; 9: 658–64. [in Russian]
10. Geroldi C, Ferrucci L, Bandinelli S et al. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J Am Ger Soc 2003; 51: 1064–71.
11. Varakin Iu.Ia. Profilaktika narushenii mozgovogo krovoobrashcheniia. Ocherki angionevrologii. Red. Z.A.Suslina. M., 2005. [in Russian]
12. De Leeuw FE, van Gijn J. Vascular dementia. Pract Neurol 2003; 3: 86–91.
13. Elias PK, Elias MF, Robbins MA et al. Blood Pressure-Related Cognitive Decline. Does Age Make a Difference? Hypertension 2004; 44: 631–6.
14. Harrington F, Saxby BK, McKeith IG et al. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–85.
15. Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol 2005; 58: 1308–15.
16. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure level and late–life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274 (23): 1846–51.
17. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M.: MEDpress-inform, 2010. [in Russian]
18. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive functions in healthy old people. J Am Geriatr Soc 1993; 41: 153–6.
19. Kilander L., Niman N., Boberg M. i dr. Vzaimosviaz' arterial'noi gipertenzii s kognitivnymi narusheniiami: Rezul'taty 20-letnego nabliudeniia 999 patsientov. Obzory klin. kardiologii. 2005; 2: 37–49. [in Russian]
20. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
21. Vogels RLC, Scheltens P, Schroeder-Tanka JM., Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Failure 2007; 9 (5): 440–9.
22. Vogels RLC, Oosterman JM, Van Harten B et al. Profile of cognitive impairment in chronic heart failure. J Ame Geriatr Soc 2007; 55 (11): 1764–70.
23. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract 2011; 23 (11): 577–85.
24. Pullicino PM, Hart J. Cognitive Impairment in congestive heart failure. Neurology 2001; 57 (11): 1945–6.
25. Alekhin A.N., Trifonova E.A., Lebedev D.S., Mikhailov E.N. Psikhologicheskie problemy v aritmologii (na modeli fibrilliatsii predserdii). Vestn. aritmologii. 2011; 63 (63): 45–54. [in Russian]
26. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol 2009; 57 (2): 143–50.
27. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. K.Rockwood, S.Gauthier, editors. London & New York: Taylor a Francis; 2006; p. 189–212.
28. Levin O.S. Kognitivnye narusheniia v praktike terapevta: zabolevaniia serdechno-sosudistoi sistemy. Consilium Medicum. 2009; 11 (2): 55–61. [in Russian]
29. Lane DA, Langman СМ, Lip GY. Illness perceptions, affective response, and healthrelated quality of life in patients with atrial fibrillation. J Psychosom Res 2009; 66 (3): 203–10.
30. Shi J, Yang SH, Stubley L et al. Hypoperfusion induces overexpression of betaamyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853 (1): 1–4.
31. Sparks DL, Scheff SW, Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131 (2): 162–9.
32. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002; 26 (1): 45–60.
33. Abend WK, Tyler H.R. Thyroid disease and the Nervous System. In: Neurology and General Medicine. The Neurological Aspects of Medical Disorders. Second edition. Ed. by M.J.Aminoff. Chapter 18. New York etc.: Churchill Livingstone 1995; p. 333–47.
34. Damulin I.V., Orazmuradov G.O. Nevrologicheskie narusheniia pri gipotireoze. Zhurn. nevrologii i psikhiatrii. 2011; 111 (3): 82–6. [in Russian]
35. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. Chapter 1:Disorders of Consciousness. New York etc.: Lange Medical Books McGraw-Hill, 2002; p. 1–70.
36. Carlomagni S, Migliaresi S, Ambrosone L et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000; 247: 273–9.
37. Glanz BI, Slonim D, Urowitz MB et al. Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 232–8.
38. Hanly JG, Fisk JD, Sherwood G et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7.
39. Hay EM, Black D, Huddy A et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6.
40. Kozora E, Thompson LL, West SG et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45.
41. Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions. Neurology 2002; 58: 1214–20.
42. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006; 85 (4): 221–8.
43. Pizova N.V. Kognitivnye narusheniia pri sistemnoi krasnoi volchanke. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2013; 12 (113): 113–7. [in Russian]
44. Laurin Mc, Holliday SL, Williams P et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64 (2): 297–303.
45. Gladman DD, Urowitz MB, Slonim D et al. Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol 2000; 27 (10): 2367–71.
46. Rogers MP, Waterhouse E, Nagel JS et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1 (4): 215–9.
47. Tomietto P, Annese V, D'Agostini S et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo 2003; 55 (3): 171–80.
48. Waterloo K, Omdal R, Sjoholm H et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001; 248 (7): 595–602.
49. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728–34.
50. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsyhol Soc 2002; 8 (3): 448–60.
51. Perneczky R, Alexopoulos P, Schmid G еt al. Cognitive reserve and its relevance for the prevention and diagnosis of dementia. Nervenarzt 2011; 82 (3): 325–30, 332–5.
52. Scarmeas N, Zarahn E, Anderson K et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003; 60: 359–65.
53. Ghaffar N, Fiati M, Feinstein A. Occupational attainment as a marker of cognitive reserve in multiple sclerosis. PLoS 2012; 7 (10): 47206.
54. Bialystok E, Craik F, Klein R, Viswanathan M. Bilingualism, aging, and cognitive control: evidence from the Simon task. Psychology and Aging 2004; 19: 290–303.
55. Bak TH, Nissan JJ, Allerhand MM, Deary IJ. Does bilingualism influence cognitive aging? Ann Neurol 2014; 75 (6): 959–63.
56. Sole-Padulles C, Bartres-Faz D, Junque C et al. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2009; 30 (7): 1114–24.
57. Erickson KI, Voss MW, Prakash RS et al. Exercise training increases size of hippocampus and improves memory. PNAS (Proceedings of the National Academy of Sciences of the USA). 2011; 108 (7): 3017–22.
58. Slobodin T.N., Goreva A.V. Kognitivnyi rezerv: prichiny snizheniia i zashchitnyi mekhanizmy. Mezhdunar. nevrol. zhurn. 2012; 3 (49): 45–51. [in Russian]
59. Fernandes MA, Craik F, Bialystok E, Kreuger S et al. Effects of bilingualism, aging, and semantic relatedness on memory under divided attention. Can J Experim Psychol Revue canadienne de psychologieexperimentale. 2007; 61 (2): 128–41.
60. Stern Y. Exploring the neural basis of cognitive reserve. J Clin Experim Neuropsychol 2003; 25 (5): 691–701.
61. Eckroth-Bucher M, Siberski J. Am J Alzheimers Dis Other Dement 2009; 24 (3): 234–45.
62. Willis S, Tennstedt S, Marsiske M et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296 (25): 2805–14.
63. Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; c. 360. [in Russian]
64. Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M., 2003; s. 150. [in Russian]
65. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res and Pract Alzheimer’s Dis 2001; 5: 57–68.
66. Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh. 2004; 5 (12): 256–61. [in Russian]
67. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
68. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer's Dis 2012; 29: 561–9.
69. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
70. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
71. Kennedy DO, Vease R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
72. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
73. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
74. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B-Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
75. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
76. www.berocca.ru
77. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
78. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.
79. Studenikin V.M., Kurbaitaeva E.M. Kal'tsiopenicheskie sostoianiia i ikh korrektsiia. Lechashchii vrach. 2010; 10: 54–6. [in Russian]
80. Studenikin V.M., Tursunkhuzhaeva S.Sh., Shelkovskii V.I. Tsink v neiropediatrii i neirodietologii. Lechashchii vrach. 2012; 1: 44–7. [in Russian]
81. Studenikin V.M., Tursunkhuzhaeva S.Sh., Zvonkova N.G. i dr. Magnii i ego preparaty v psikhonevrologii. Effektivnaia farmakoterapiia. Nevrologiia i psikhiatriia. 2012; 4 (8–12): 58–60. [in Russian]
Авторы
Н.В.Пизова*
ГБОУ ВПО Ярославский государственный медицинский университет Минздрава России. 150000, Россия, Ярославль, ул. Революционная, д. 5
*5pizova@yandeх.ru
Yaroslavl State Medical University of the Ministry of Health of the Russian Federation. 150000, Russian Federation, Yaroslavl, ul. Revoliutsionnaia, d. 5
*5pizova@yandeх.ru
ГБОУ ВПО Ярославский государственный медицинский университет Минздрава России. 150000, Россия, Ярославль, ул. Революционная, д. 5
*5pizova@yandeх.ru
________________________________________________
Yaroslavl State Medical University of the Ministry of Health of the Russian Federation. 150000, Russian Federation, Yaroslavl, ul. Revoliutsionnaia, d. 5
*5pizova@yandeх.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.